References
- Babjuk M, Burger M, Zigeuner R, et al (2013). EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol, 64, 639-53. https://doi.org/10.1016/j.eururo.2013.06.003
- Basiri A, Shakhssalim N, Jalaly NY, et al (2014). Difference in the incidences of the most prevalent urologic cancers from 2003 to 2009 in Iran. Asian Pac J Cancer Prev, 15, 1459-63. https://doi.org/10.7314/APJCP.2014.15.3.1459
- Beutler E, Waalen J (2006). The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood, 107, 1747-50. https://doi.org/10.1182/blood-2005-07-3046
- Birgegard G, Aapro MS, Bokemeyer C, et al (2005). Cancerrelated anemia: pathogenesis, prevalence and treatment. Oncol, 68, 3-11. https://doi.org/10.1159/000083128
- Burger M, Catto JW, Dalbagni G, et al (2013). Epidemiology and risk factors of urothelial bladder cancer. Eur Urol, 63, 234-41. https://doi.org/10.1016/j.eururo.2012.07.033
- Gierth M, Mayr R, Aziz A, et al (2015). Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy. J Cancer Res Clin Oncol, 141, 1819-26. https://doi.org/10.1007/s00432-015-1957-7
- Hutterer GC, Krieger D, Mrsic E, et al (2015). Preoperative leukocytosis, thrombocytosis and anemia as potential prognostic factors in non-metastatic renal cell carcinoma. Anticancer Res, 35, 3463-9.
- Ikeda M, Matsumoto K, Nishi M, et al (2014). Comparison of radical cystectomy and chemoradiotherapy in patients with locally advanced bladder cancer. Asian Pac J Cancer Prev, 15, 6519-24. https://doi.org/10.7314/APJCP.2014.15.16.6519
- Kikuchi E, Margulis V, Karakiewicz P, et al (2009). Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol, 27, 612-8. https://doi.org/10.1200/JCO.2008.17.2361
- Lammers RJ, Hendriks JC, Rodriguez Faba OR, et al (2016). Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediaterisk non-muscle-invasive bladder cancer, including external validation. World J Urol, 34, 173-80. https://doi.org/10.1007/s00345-015-1598-0
- Mercadante S, Gebbia V, Marrazzo A, Filosto S (2000). Anemia in cancer: pathophysiology and treatment. Cancer Treat Rev, 26, 303-11. https://doi.org/10.1053/ctrv.2000.0181
- Milojevic B, Dzamic Z, Kajmakovic B, et al (2015). Prognostic impact of preoperative anemia on urothelial and extraurothelial recurrence in patients with upper tract urothelial carcinoma. Clin Genitourin Cancer, 13, 485-91. https://doi.org/10.1016/j.clgc.2015.03.007
- Pagano F, Bassi P, Galetti TP, et al (1991). Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol, 145, 45-50. https://doi.org/10.1016/S0022-5347(17)38244-7
- Panneerselvam J, Park HK, Zhang J, et al (2012). FAVL impairment of the Fanconi anemia pathway promotes the development of human bladder cancer. Cell Cycle, 11, 2947-55. https://doi.org/10.4161/cc.21400
- Rink M, Cha EK, Green D, et al (2012a). Biomolecular predictors of urothelial cancer behavior and treatment outcomes. Curr Urol Rep, 13, 122-35. https://doi.org/10.1007/s11934-012-0237-1
- Rink M, Fajkovic H, Cha EK, et al (2012b). Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol, 61, 854-5. https://doi.org/10.1016/j.eururo.2011.12.055
- Rink M, Sharifi N, Fritsche HM, et al (2014). Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol, 191, 316-22. https://doi.org/10.1016/j.juro.2013.09.010
- Thrasher JB, Frazier HA, Robertson JE, Dodge RK, Paulson DF (1994). Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer, 73, 1708-15. https://doi.org/10.1002/1097-0142(19940315)73:6<1708::AID-CNCR2820730626>3.0.CO;2-J
- Van Belle SJ, Cocquyt V (2003). Impact of hemoglobin levels on the outcome of cancers treated with chemotherapy. Crit Rev Oncol Hematol, 47, 1-11. https://doi.org/10.1016/S1040-8428(03)00093-3
Cited by
- Prognostic implications of preoperative anemia in urothelial carcinoma: A meta-analysis vol.12, pp.2, 2017, https://doi.org/10.1371/journal.pone.0171701
- Prognostic impact of preoperative anemia on non-muscle-invasive bladder carcinoma treated with GreenLight laser vaporization vol.32, pp.2, 2017, https://doi.org/10.1007/s10103-016-2133-2
- Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non–muscle-invasive bladder cancer patients vol.7, pp.1, 2017, https://doi.org/10.1038/s41598-017-01532-7